Published in Environ Health Perspect on January 01, 2005
Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health (2009) 1.74
Adult lead exposure: time for change. Environ Health Perspect (2006) 1.20
Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry (2009) 1.20
Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health (2008) 1.06
Longitudinal associations between lead dose and renal function in lead workers. Environ Res (2008) 0.79
The Effects of Lead Exposure on Serum Uric Acid and Hyperuricemia in Chinese Adults: A Cross-Sectional Study. Int J Environ Res Public Health (2015) 0.78
Associations of uric acid with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect (2005) 0.78
Surveillance of childhood blood lead levels in Chengdu, China in 2010-2011. Singapore Med J (2015) 0.75
The relevance of hyperuricemia and metabolic syndrome and the effect of blood lead level on uric Acid concentration in steelmaking workers. Ann Occup Environ Med (2013) 0.75
Cumulative lead exposure and tooth loss in men: the normative aging study. Environ Health Perspect (2009) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (2003) 5.47
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A role for uric acid in the progression of renal disease. J Am Soc Nephrol (2002) 3.77
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37
In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect (1994) 1.74
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol (1995) 1.70
Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol (2002) 1.64
Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria. Clin Chem (1986) 1.59
Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol (1987) 1.54
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol (2001) 1.46
Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol (2002) 1.39
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect (1995) 1.37
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med (2003) 1.29
Occupational lead nephropathy. Am J Med (1975) 1.29
Pathogenesis of hyperuricemia in saturinine gout. N Engl J Med (1969) 1.29
Micromethod for lead determination in whole blood by atomic absorption, with use of the graphite furnace. Clin Chem (1975) 1.22
Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med (1994) 1.18
Nephropathy in chronic lead poisoning. Arch Intern Med (1966) 1.17
Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int (1992) 1.17
The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol (1978) 1.07
Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate. Am J Kidney Dis (2002) 1.07
Contamination of in vivo bone-lead measurements. Phys Med Biol (2000) 1.06
Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol (2000) 1.04
In vivo measurements of lead in bone using a 109Cd 'spot' source. Basic Life Sci (1993) 1.02
Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation (2001) 1.01
Pathogenesis of lead-induced hypertension: role of oxidative stress. J Hypertens Suppl (2002) 1.01
Lead absorption and renal dysfunction in a South African battery factory. Occup Environ Med (1998) 0.98
Chronic effects of lead on the renin-angiotensin system. Environ Health Perspect (1988) 0.97
Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology (1992) 0.97
Environmental lead exposure and urate excretion in the general population. Am J Med (2002) 0.95
Calculating bone-lead measurement variance. Environ Health Perspect (2000) 0.93
Relationship between blood lead levels and renal function in lead battery workers. Int Arch Occup Environ Health (2002) 0.90
Experimental model of lead nephropathy. III. Continuous low-level lead administration. Arch Environ Health (1993) 0.89
Lead and the kidney. Curr Top Pathol (1971) 0.89
Lead nephropathy, gout, and hypertension. Am J Med Sci (1993) 0.87
Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant (1996) 0.86
Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foods. Cancer Epidemiol Biomarkers Prev (2000) 0.86
The renal excretion of urate in chronic lead nephropathy. Australas Ann Med (1965) 0.84
Is lead exposure the principal cause of essential hypertension? Med Hypotheses (2002) 0.83
Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout. Kidney Int (2001) 0.83
The relative contributions of tubular reabsorption and secretion to urate excretion in lead nephropathy. Aust N Z J Med (1971) 0.81
Abnormal renal urate homeostasis in systemic disorders. Nephron (1975) 0.79
Purine metabolism in patients with gout: the role of lead. Nephron (1997) 0.77
The relationship of serum uric acid to subclinical blood lead. Rheumatol Rehabil (1981) 0.77
A high-resolution map of human evolutionary constraint using 29 mammals. Nature (2011) 8.67
Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA (2003) 4.33
The built environment and obesity: a systematic review of the epidemiologic evidence. Health Place (2009) 3.98
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53
Recommendations for medical management of adult lead exposure. Environ Health Perspect (2006) 3.38
Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol (2003) 2.95
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90
Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect (2008) 2.81
Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis (2006) 2.64
Texaco and its consultants. Int J Occup Environ Health (2005) 2.55
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Diversity and dynamics of the Drosophila transcriptome. Nature (2014) 2.47
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis (2008) 2.35
High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania. JAMA Intern Med (2013) 2.27
Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study. Lancet (2011) 2.24
Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis (2009) 2.18
Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med (2012) 2.14
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc (2013) 2.06
Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial. Am J Kidney Dis (2012) 2.00
microRNA-101 is a potent inhibitor of autophagy. EMBO J (2011) 2.00
A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect (2005) 1.99
Neighborhoods and obesity in older adults: the Baltimore Memory Study. Am J Prev Med (2006) 1.96
Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect (2006) 1.94
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91
The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int (2008) 1.83
Lasagna plots: a saucy alternative to spaghetti plots. Epidemiology (2010) 1.83
Increases in hypertension and blood pressure during pregnancy with increased bone lead levels. Am J Epidemiol (2002) 1.82
Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry (2008) 1.81
A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environ Health Perspect (2007) 1.79
Population-based inorganic mercury biomonitoring and the identification of skin care products as a source of exposure in New York City. Environ Health Perspect (2010) 1.76
Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res (2010) 1.75
Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med (2010) 1.67
MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One (2010) 1.64
Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol (2006) 1.59
Assessment of prenatal mercury exposure in a predominately Caribbean immigrant community in Brooklyn, NY. J Environ Monit (2012) 1.57
Toxic trace metals and human oocytes during in vitro fertilization (IVF). Reprod Toxicol (2010) 1.57
Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry (2007) 1.52
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis (2011) 1.51
Bone lead levels and blood pressure endpoints: a meta-analysis. Epidemiology (2008) 1.48
Modeling age and retest processes in longitudinal studies of cognitive abilities. Psychol Aging (2004) 1.48
Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology (2005) 1.47
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol (2015) 1.46
Social insect genomes exhibit dramatic evolution in gene composition and regulation while preserving regulatory features linked to sociality. Genome Res (2013) 1.45
Multivariate modeling of age and retest in longitudinal studies of cognitive abilities. Psychol Aging (2005) 1.45
Change in blood lead concentration up to 1 year after a gunshot wound with a retained bullet. Am J Epidemiol (2004) 1.45
High-dose mycophenolate mofetil in the treatment of posttransplant glomerular disease in the allograft: a case series. Nephron Clin Pract (2004) 1.40
Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus. Atherosclerosis (2013) 1.37
Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol (2006) 1.35
Predictors of Indoor Radon Concentrations in Pennsylvania, 1989-2013. Environ Health Perspect (2015) 1.34
New families of human regulatory RNA structures identified by comparative analysis of vertebrate genomes. Genome Res (2011) 1.32
High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J Am Soc Nephrol (2005) 1.29
Functional principal component model for high-dimensional brain imaging. Neuroimage (2011) 1.28
Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis (2012) 1.25
Identifying and addressing barriers to African American and non-African American families' discussions about preemptive living related kidney transplantation. Prog Transplant (2011) 1.24
Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol (2013) 1.24
The longitudinal association of lead with blood pressure. Epidemiology (2003) 1.24
Low-level prenatal and postnatal blood lead exposure and adrenocortical responses to acute stress in children. Environ Health Perspect (2008) 1.23
Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Neighborhood psychosocial hazards and cardiovascular disease: the Baltimore Memory Study. Am J Public Health (2008) 1.22
Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc (2005) 1.21
ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect (2002) 1.20
Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature. J Hosp Med (2010) 1.19
Frailty and falls among adult patients undergoing chronic hemodialysis: a prospective cohort study. BMC Nephrol (2013) 1.19
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. J Clin Invest (2015) 1.18
Inappropriate survey design analysis of the Korean National Health and Nutrition Examination Survey may produce biased results. J Prev Med Public Health (2013) 1.18
MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells. BMC Cancer (2012) 1.16
Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol (2012) 1.16
DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum Reprod (2012) 1.16
Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ Health Perspect (2005) 1.14
National estimates of blood lead, cadmium, and mercury levels in the Korean general adult population. Int Arch Occup Environ Health (2010) 1.14
Findings on brain MRI from research studies of occupational exposure to known neurotoxicants. AJR Am J Roentgenol (2006) 1.14
Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis (2007) 1.12
Neighborhood-level cohesion and disorder: measurement and validation in two older adult urban populations. J Gerontol B Psychol Sci Soc Sci (2009) 1.12
Are brain volumes based on magnetic resonance imaging mediators of the associations of cumulative lead dose with cognitive function? Am J Epidemiol (2007) 1.10
Estimating the half-lives of PCB congeners in former capacitor workers measured over a 28-year interval. J Expo Sci Environ Epidemiol (2010) 1.10
Measurements of lead in human tibiae. A comparison between K-shell x-ray fluorescence and electrothermal atomic absorption spectrometry. Phys Med Biol (2002) 1.10
Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol (2013) 1.10
African American and non-African American patients' and families' decision making about renal replacement therapies. Qual Health Res (2012) 1.09
Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol (2004) 1.09
Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥ 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract (2012) 1.09
Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets. Int J Qual Health Care (2005) 1.08
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res (2007) 1.08
Cumulative lead dose and cognitive function in older adults. Epidemiology (2009) 1.07
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care (2012) 1.07
Neighborhood psychosocial hazards and the association of cumulative lead dose with cognitive function in older adults. Am J Epidemiol (2009) 1.06
Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2012) 1.06
Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health (2008) 1.06